Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P79
Within normal range
vs 2Y Ago
0.5x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 28.14% |
| Q2 2025 | 26.68% |
| Q1 2025 | 6.99% |
| Q4 2024 | 38.32% |
| Q3 2024 | -38.50% |
| Q2 2024 | 17.85% |
| Q1 2024 | -35.39% |
| Q4 2023 | -24.06% |
| Q3 2023 | 51.68% |
| Q2 2023 | -78.33% |
| Q1 2023 | 36.42% |
| Q4 2022 | 45.07% |
| Q3 2022 | -139.21% |
| Q2 2022 | 4.76% |
| Q1 2022 | -33.81% |
| Q4 2021 | 45.92% |
| Q3 2021 | -105.91% |
| Q2 2021 | -48.25% |
| Q1 2021 | 25.66% |
| Q4 2020 | 22.21% |
| Q3 2020 | -39.14% |
| Q2 2020 | -0.55% |
| Q1 2020 | -77.89% |
| Q4 2019 | 7.03% |
| Q3 2019 | -28.70% |
| Q2 2019 | -150.94% |
| Q1 2019 | 202.44% |
| Q4 2018 | 8.33% |
| Q3 2018 | -2.68% |
| Q2 2018 | -0.72% |
| Q1 2018 | -31.52% |
| Q4 2017 | 27.72% |
| Q3 2017 | -101.47% |
| Q2 2017 | 47.12% |
| Q1 2017 | 10.82% |
| Q4 2016 | 26.86% |
| Q3 2016 | 39.10% |
| Q2 2016 | -27.81% |
| Q1 2016 | -32.96% |
| Q4 2015 | 4.61% |